Process View
The network for 'dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.
| Name | Description | Probability | Func Analog Organism |
|---|
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| XIAP | X-linked inhibitor of apoptosis | 0.998 | |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.992 | |
| RB1 | retinoblastoma 1 | 0.979 | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.979 | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.974 | |
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.964 | |
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.900 | |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.829 | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.750 | |
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.729 | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.716 | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.708 | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.658 | |
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.636 | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.579 | |
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.554 | |
| POU3F2 | POU class 3 homeobox 2 | 0.533 | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.395 | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.318 | |
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.299 | |
| FADD | Fas (TNFRSF6)-associated via death domain | 0.276 | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.258 | |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.228 | |
| TP53 | tumor protein p53 | 0.193 | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.177 | |
| LRDD | leucine-rich repeats and death domain containing | 0.165 | |
| POU5F1 | POU class 5 homeobox 1 | 0.139 | |
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.126 | |
| SMAD7 | SMAD family member 7 | 0.124 | |
| IER3 | immediate early response 3 | 0.118 | |
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.113 | |
| NLRC4 | NLR family, CARD domain containing 4 | 0.110 | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.095 | |
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.094 | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.089 | |
| CCND1 | cyclin D1 | 0.088 | |
| CDK2 | cyclin-dependent kinase 2 | 0.085 | |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.069 | |
| PAX3 | paired box 3 | 0.067 | |
| PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.052 | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.051 | |
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.046 | |
| DAXX | death-domain associated protein | 0.042 | |
| CCND3 | cyclin D3 | 0.040 | |
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.036 | |
| CDK6 | cyclin-dependent kinase 6 | 0.033 | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.031 | |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.030 | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.025 | |
| RBL2 | retinoblastoma-like 2 (p130) | 0.023 | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.022 | |
| MAPK1 | mitogen-activated protein kinase 1 | 0.020 | |
| TGIF1 | TGFB-induced factor homeobox 1 | 0.020 | |
| FOXD3 | forkhead box D3 | 0.020 | |
| CCNE1 | cyclin E1 | 0.020 | |
| DZIP1 | DAZ interacting protein 1 | 0.018 | |
| HDAC4 | histone deacetylase 4 | 0.017 | |
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.017 | |
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.017 | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.017 | |
| IFI16 | interferon, gamma-inducible protein 16 | 0.016 | |
| NUCB2 | nucleobindin 2 | 0.014 | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.012 | |
| MARCKSL1 | MARCKS-like 1 | 0.012 | |
| NOTCH1 | notch 1 | 0.012 | |
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.010 | |
| PLSCR1 | phospholipid scramblase 1 | 0.010 |
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| Trp53 | transformation related protein 53 | 1.000 | |
| Trp63 | transformation related protein 63 | 0.940 | |
| Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.925 | |
| Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.910 | |
| Mdm4 | transformed mouse 3T3 cell double minute 4 | 0.907 | |
| Apc | adenomatosis polyposis coli | 0.881 | |
| Rb1 | retinoblastoma 1 | 0.867 | |
| Pten | phosphatase and tensin homolog | 0.845 | |
| Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.775 | |
| Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.597 | |
| Kit | kit oncogene | 0.528 | |
| Trp73 | transformation related protein 73 | 0.479 | |
| Col1a1 | collagen, type I, alpha 1 | 0.436 | |
| Cdkn2a | cyclin-dependent kinase inhibitor 2A | 0.410 | |
| Rara | retinoic acid receptor, alpha | 0.402 | |
| Brca1 | breast cancer 1 | 0.383 | |
| Daxx | Fas death domain-associated protein | 0.321 | |
| Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.317 | |
| Sox9 | SRY-box containing gene 9 | 0.296 | |
| Thbs1 | thrombospondin 1 | 0.288 | |
| Fgfr2 | fibroblast growth factor receptor 2 | 0.265 | |
| Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.261 | |
| Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.241 | |
| Braf | Braf transforming gene | 0.224 | |
| Meox2 | mesenchyme homeobox 2 | 0.182 | |
| Vhl | von Hippel-Lindau tumor suppressor | 0.169 | |
| Sfn | stratifin | 0.135 | |
| Rxra | retinoid X receptor alpha | 0.132 | |
| Skil | SKI-like | 0.130 | |
| Esr2 | estrogen receptor 2 (beta) | 0.118 | |
| Runx1 | runt related transcription factor 1 | 0.107 | |
| Nf1 | neurofibromatosis 1 | 0.096 | |
| Hif1a | hypoxia inducible factor 1, alpha subunit | 0.088 | |
| Cdkn2c | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.075 | |
| Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.075 | |
| Brca2 | breast cancer 2 | 0.075 | |
| Ptch1 | patched homolog 1 | 0.073 | |
| Rag1 | recombination activating gene 1 | 0.072 | |
| Psen1 | presenilin 1 | 0.072 | |
| Esr1 | estrogen receptor 1 (alpha) | 0.060 | |
| E2f1 | E2F transcription factor 1 | 0.053 | |
| Nf2 | neurofibromatosis 2 | 0.051 | |
| Stk11 | serine/threonine kinase 11 | 0.047 | |
| Ahr | aryl-hydrocarbon receptor | 0.045 | |
| Ccnd1 | cyclin D1 | 0.043 | |
| Shh | sonic hedgehog | 0.043 | |
| Gadd45a | growth arrest and DNA-damage-inducible 45 alpha | 0.040 | |
| Dsc3 | desmocollin 3 | 0.038 | |
| Emx2 | empty spiracles homolog 2 (Drosophila) | 0.034 | |
| Krt14 | keratin 14 | 0.034 | |
| Prkdc | protein kinase, DNA activated, catalytic polypeptide | 0.034 | |
| Hipk1 | homeodomain interacting protein kinase 1 | 0.033 | |
| Smn1 | survival motor neuron 1 | 0.031 | |
| Smad3 | MAD homolog 3 (Drosophila) | 0.031 | |
| Elavl1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | 0.030 | |
| Rbl1 | retinoblastoma-like 1 (p107) | 0.027 | |
| Vegfa | vascular endothelial growth factor A | 0.027 | |
| Atm | ataxia telangiectasia mutated homolog (human) | 0.026 | |
| Irf6 | interferon regulatory factor 6 | 0.026 | |
| Mybl2 | myeloblastosis oncogene-like 2 | 0.026 | |
| Hr | hairless | 0.025 | |
| Gli3 | GLI-Kruppel family member GLI3 | 0.025 | |
| Tsc1 | tuberous sclerosis 1 | 0.025 | |
| Yap1 | yes-associated protein 1 | 0.024 | |
| Xpa | xeroderma pigmentosum, complementation group A | 0.020 | |
| Hhat | hedgehog acyltransferase | 0.019 | |
| Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.019 | |
| Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.018 | |
| Msh2 | mutS homolog 2 (E. coli) | 0.017 | |
| Lef1 | lymphoid enhancer binding factor 1 | 0.017 | |
| Hprt | hypoxanthine guanine phosphoribosyl transferase | 0.017 | |
| Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.017 | |
| Tcf3 | transcription factor 3 | 0.016 | |
| Nfya | nuclear transcription factor-Y alpha | 0.016 | |
| Rarb | retinoic acid receptor, beta | 0.016 | |
| Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.016 | |
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.015 | |
| Mta2 | metastasis-associated gene family, member 2 | 0.014 | |
| Notch2 | Notch gene homolog 2 (Drosophila) | 0.014 | |
| Sin3a | transcriptional regulator, SIN3A (yeast) | 0.013 | |
| Gata3 | GATA binding protein 3 | 0.013 | |
| Cdk2 | cyclin-dependent kinase 2 | 0.013 | |
| Kitl | kit ligand | 0.013 | |
| Cdx2 | caudal type homeobox 2 | 0.012 | |
| Men1 | multiple endocrine neoplasia 1 | 0.012 | |
| Isl1 | ISL1 transcription factor, LIM/homeodomain | 0.012 | |
| Cyp21a1 | cytochrome P450, family 21, subfamily a, polypeptide 1 | 0.011 | |
| Tgfb1 | transforming growth factor, beta 1 | 0.011 | |
| Rnf111 | ring finger 111 | 0.011 | |
| Egfr | epidermal growth factor receptor | 0.011 | |
| Krt19 | keratin 19 | 0.011 | |
| Cxcr4 | chemokine (C-X-C motif) receptor 4 | 0.011 | |
| Ar | androgen receptor | 0.011 | |
| Bard1 | BRCA1 associated RING domain 1 | 0.011 | |
| Bcl2l1 | BCL2-like 1 | 0.011 | |
| Lrp6 | low density lipoprotein receptor-related protein 6 | 0.011 | |
| Adam17 | a disintegrin and metallopeptidase domain 17 | 0.010 | |
| Gtse1 | G two S phase expressed protein 1 | 0.010 | |
| Lrdd | leucine-rich and death domain containing | 0.010 | |
| Wrn | Werner syndrome homolog (human) | 0.010 |